LEXARIA BIOSCIENCE CORP (LEXX) Earnings History & Surprises
NASDAQ:LEXX • US52886N4060
0.728 USD
0 (-0.21%)
At close: Mar 10, 2026
0.7752 USD
+0.05 (+6.48%)
After Hours: 3/10/2026, 8:00:03 PM
Past quarterly earnings results for LEXARIA BIOSCIENCE CORP (LEXX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateApr 13, 2026
PeriodQ2 / 2026
EPS Estimate-$0.10
Revenue Estimate51K
Last Reported
Release DateJan 13, 2026
PeriodQ1 / 2026
EPS Reported-$0.07
EPS Surprise 47.21%
Revenue Surprise -100.00%
Beat Rate
25%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q1 2026 | -0.07 | -0.13 | 47.21% | 56.25% | 102K | -100.00% | -100.00% | |
| Q4 2025 | -0.13 | -0.16 | 18.65% | 7.14% | 174K | 139.74K | 24.52% | 107.14% |
| Q3 2025 | -0.21 | -0.16 | -31.41% | -61.54% | 174K | 93.157K | 86.78% | 107.14% |
| Q2 2025 | -0.15 | -0.16 | 5.12% | -150.00% | 174K | 139.74K | 24.52% | 20.00% |
| Q1 2025 | -0.16 | -0.12 | -30.72% | -23.08% | 183.92K | 102K | 80.31% | 21.56% |
| Q4 2024 | -0.14 | -0.11 | -24.78% | -16.67% | 84K | 178.5K | -52.94% | - |
| Q3 2024 | -0.13 | -0.11 | -23.34% | 64.86% | 84K | 153K | -45.10% | -9.82% |
| Q2 2024 | -0.06 | -0.10 | 41.18% | - | 145K | - | 262.50% | |
| Q1 2024 | -0.13 | -0.11 | -15.86% | 56.67% | 151.3K | - | 51.30% | |
| Q4 2023 | -0.12 | -0.14 | 12.85% | 50.00% | 178.5K | -100.00% | -100.00% | |
| Q3 2023 | -0.37 | -0.26 | -45.10% | 9.76% | 93.15K | 81.6K | 14.15% | -6.85% |
| Q2 2023 | - | - | 40K | - | 33.33% | |||
| Q1 2023 | -0.30 | - | - | 100K | - | 900.00% | ||
| Q4 2022 | -0.24 | -0.21 | -12.04% | -10.09% | 110K | 198.9K | -44.70% | 266.67% |
| Q3 2022 | -0.41 | -0.29 | -43.56% | -2.50% | 100K | 122.4K | -18.30% | -50.00% |
| Q2 2022 | -0.25 | 0.21 | -216.71% | - | 30K | 153K | -80.39% | -84.21% |
| Q1 2022 | - | - | 10K | - | -96.67% | |||
| Q4 2021 | -0.22 | -0.23 | 7.08% | - | 30K | 255K | -88.24% | -50.00% |
| Q3 2021 | -0.40 | - | - | 200K | - | 400.00% | ||
| Q2 2021 | - | - | 190K | - | -5.00% | |||
| Q1 2021 | - | - | 300K | - | 2,900.00% | |||
| Q4 2020 | - | - | 60K | - | - | |||
| Q3 2020 | - | - | 40K | - | - | |||
| Q2 2020 | - | - | 200K | - | - | |||
| Q1 2020 | - | - | 10K | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
9.89%
Max EPS beat (4)
47.21%
Min EPS beat (4)
-31.41%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
8.95%
Max Revenue beat (4)
86.78%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, LEXX has beaten EPS estimates in 3 out of 4 releases
LEXX has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, LEXX has beaten the EPS estimates by 9.9% on average.
In the last 4 quarters, LEXX has beaten the revenue estimates by 9.0% on average.
LEXARIA BIOSCIENCE CORP / LEXX Earnings FAQ
Can you provide the last earnings date for LEXARIA BIOSCIENCE CORP?
LEXARIA BIOSCIENCE CORP (LEXX) last reported earnings on 1/13/2026.
Did LEXX stock beat earnings estimates in the most recent quarter?
LEXARIA BIOSCIENCE CORP (LEXX) beat EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does LEXX stock beat earnings estimates?
In the last 4 quarters, LEXARIA BIOSCIENCE CORP (LEXX) has beaten EPS estimates in 3 out of 4 releases.